Alternatives to Combat Medical
Combat Medical is a Biotechnology tool: optimizing the delivery and efficacy of cancer therapeutics through hyperthermic intravesical chemotherapy. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Combat Medical
- Website
Francis Medical51MedTechMaple Grove, United States$156.0MDeveloping minimally invasive water vapor ablation therapy to treat prostate, kidney, and bladder cancer.
- Website
NxThera41Medical DevicesMaple Grove, United States$3.3MDeveloper of minimally invasive thermal water vapor therapy for treating benign prostatic hyperplasia (BPH).
- Website HIHistoSonics47BiotechnologyMinneapolis, USA$40.0M
Developing a new histotripsy therapeutic platform for cancer treatment.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Kite Pharma66BiotechnologySanta Monica, United States$421.2MBiotechnology company developing and commercializing cell therapies for cancer treatment.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
Pixelgen Technologies62BiotechnologyStockholm, Sweden$43.5MA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
4D Path59BiotechnologyNewton, USA$17.4MPersonalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.
- Website
Mironid59BiotechnologyGlasgow, United Kingdom$46.0MBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Website
Janux Therapeutics57BiotechnologySan Diego, USA$181.0MA clinical-stage biopharmaceutical company developing novel immunotherapies.
- Website
KaliVir Immunotherapeutics, Inc.57BiotechnologyPittsburgh, United States$14.0MClinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
- EAEarendil Labs56BiotechnologyBeijing, China$787.0M
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
- Website CRCrossbow Therapeutics55BiotechnologyCambridge, United States$157.0M
Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.
- Website
Spiderwort55BiotechnologyOttawa, Canada$16.2MBiotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.
- Website
Sinopia Biosciences54BiotechnologySan Diego, USA$2.2MBiotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
Showing the 20 closest matches. See the rest on the Combat Medical profile.